Trial Profile
A randomised, 2-arm, parallel group study assessing efficacy and tolerability of titrated transdermal buprenorphine in patients with moderate to severe chronic non malignant pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Oct 2020
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Grunenthal
- 14 Nov 2018 Status changed from recruiting to completed.
- 01 Jun 2011 New trial record